← Back to headlines
Plus Therapeutics Beats Q4 EPS and Revenue Estimates
Plus Therapeutics reported a GAAP EPS of -$0.29, beating estimates by $0.01, and revenue of $5.21 million, surpassing expectations by $0.14 million.
12 Mar, 20:53 — 12 Mar, 20:53
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Philippines receives diesel shipment from Malaysia
just now
DPWH Vows Completion of Stalled Laguna Medical Center Building by 2027
just now